Last reviewed · How we verify
Chewable tablets
At a glance
| Generic name | Chewable tablets |
|---|---|
| Sponsor | The Hospital for Sick Children |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mental Balance Study (NA)
- Chewable Tablets Produced by Three-Dimensional Printing: A Sensory Acceptability Study in Children and Adolescents
- Effect of TCI188 Probiotic on Oral Health (NA)
- The Effect of Vitamin C Supplementation on Gut Microbiota Composition and Function in Healthy Adults (NA)
- Oral Probiotics for Halitosis in Healthy Adults (NA)
- Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma (PHASE2)
- Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy
- Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |